Search Results 2021-2030 of 13641 for monoclonal antibody

  1. Medical Research & Education - Mayo Clinic News Network

    Biotherapeutics. Training the workforce of the future in CAR T-cell therapy ; Mayo Clinic expert answers questions about antibody testing for COVID-19 featured ...

  2. A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib - Mayo Clinic

    Patients with positive HCV antibody are eligible only if the polymerase ... antibodies). Testing is not required for assessment of eligibility for the ...

  3. Health Topics - Mayo Clinic News Network

    Mayo Clinic Q&A podcast: Delegate, delete, do — How to integrate work, · Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease.

  4. Study Of Pomalidomide For Treatment Of Relapsed/Refractory Primary Central Nervous System Lymphoma And Newly Diagnosed Or Relapsed/Refractory Intraocular Lymphoma - Mayo Clinic

    ... antibody (HBcIgM Ab), hepatitis B surface antigen (HBsAg) and hepatitis C antibody screen (HCV Ab Scrn) w/Reflex testing are required at screening for all ...

  5. Selective IgA deficiency - Diagnosis and treatment - Mayo Clinic

    A lack of the disease-fighting antibody called immunoglobulin A (IgA) may cause frequent infections or serious complications.

  6. A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870 - Mayo Clinic

    ... antibodies (anti-HCV), and/or HIV antibodies. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up ...

  7. Ph 1b Study To Evaluate GSK2110183 In Combination With Bortezomib And Dexamethasone In Subjects With Multiple Myeloma - Mayo Clinic

    Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral load. If hepatitis C antibody is positive, confirmatory tests may ...

  8. Targeting Matrix Metalloproteinases Using Tissue Inhibitors - Proteases in Cancer Laboratory - Mayo Clinic Research

    We're exploring the idea that TIMPs , like antibodies, can be engineered as targeted protein therapeutics of remarkable affinity and exquisite selectivity.

  9. Hematology - Clinical trials

    The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

  10. Hematology - Clinical trials

    The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...